No items found.
Left chevron

Go Back

Pharmacology

TZDs (Pioglitazone) for Type 2 Diabetes: Pharmacology Review

TZDs (Pioglitazone & Rosiglitazone) explained: type 2 diabetes (T2DM) pharmacology, PPAR-gamma mechanism, clinical use, side effects, and contraindications.

Video thumbnail

To view this video, please enable marketing cookies from Cookie Preferences in the footer.

Horizontal dot pattern

In this lecture from This is Why, Dr. Busti will break down pioglitazone and the thiazolidinediones (TZDs) so you can confidently explain the mechanism, clinical use, side effects, and key contraindications for type 2 diabetes (T2DM).

You’ll learn how to:
- TZDs (pioglitazone): where they fit in type 2 diabetes (T2DM) therapy
- Mechanism of action: PPAR-γ agonist → increased insulin sensitivity (muscle/adipose) and improved glucose utilization
- Expected impact on A1C reduction and how long these drugs take to show benefit
- Practical comparisons: pioglitazone vs rosiglitazone

Side effects & safety (high yield)
- Weight gain and edema / fluid retention
- Heart failure risk (when to avoid TZDs)
- Fracture risk with TZDs

Drugs covered for SEO / review
- Pioglitazone (primary focus)
- Thiazolidinediones / TZDs (drug class)
- Rosiglitazone (comparison)


Chapter Table of Contents

00:00 TZDs Overview in Type 2 Diabetes: Why This Class Fell Out of Favor
01:28 TZD Agents: Why Only Pioglitazone Remains (Rosiglitazone History)
01:56 Indications: T2DM + Pioglitazone for MASH (Fatty Liver Disease)
02:42 Net Benefit Reality: Modest A1C Drop vs Weight Gain & Fluid Retention
03:23 Mechanism of Action: PPAR-γ Agonism & Improved Insulin Sensitivity
04:34 Where TZDs Fit in T2DM Treatment (Non-Insulin Options Compared)
06:47 Comorbidities: When to Avoid TZDs (HF, CAD, Fracture Risk)
09:00 Absolute Contraindication: NYHA Class III/IV Heart Failure Warning
10:32 Evidence Spotlight: PROactive Trial (Benefits + Tradeoffs)
12:03 Key Adverse Effects: Anemia, Macular Edema, Bladder Cancer Signals
13:25 Drug Interactions: CYP Effects & Gemfibrozil Increasing Levels
14:30 Monitoring Checklist: A1C, LFTs, CBC, Edema/Fluid Status + Wrap-Up


If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#pioglitazone #thiazolidinediones #tzd #type2diabetes #busti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This is why - membership

More than just access—it’s where understanding deepens.

Create a free account or log in to gain access to this content!

Dot pattern graphic

Dive Deeper

Bonus Video (ad free)

Deep Dive video thumbnail

To view this video, please enable marketing cookies.

Downloads

Antidiabetic Agents Lecture Tables

Dive Deeper

Bonus Video

Downloads

Antidiabetic Agents Lecture Tables